Advanos Announces Board Approval of Q1 2026 Consolidated Financial Report
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Advanos' board of directors approved the Q1 2026 consolidated financial report. Key figures include cumulative operating revenue of NT$3.03 billion and basic EPS of NT$0.76.